title: Reduction of human menopausal gonadotropin dose before coasting prevents severe ovarian hyperstimulation syndrome with minimal cycle cancellation.
authors.affiliation: Egyptian IVF-ET Center, Cairo, Egypt.
authors.forename: M A
authors.initials: MA
authors.lastname: Aboulghar
authors.forename: R T
authors.initials: RT
authors.lastname: Mansour
authors.forename: G I
authors.initials: GI
authors.lastname: Serour
authors.forename: C A
authors.initials: CA
authors.lastname: Rhodes
authors.forename: Y M
authors.initials: YM
authors.lastname: Amin
mesh_terms: D000328:Adult; D006063:Chorionic Gonadotropin / Q000008:administration & dosage / Q000494:pharmacology; D004958:Estradiol / Q000097:blood; D005260:Female; D005306:Fertilization; D005307:Fertilization in Vitro; D006801:Humans; D008423:Maternal Age; D008596:Menotropins / Q000008:administration & dosage* / Q000494:pharmacology*; D008598:Menstruation / Q000187:drug effects*; D016471:Ovarian Hyperstimulation Syndrome / Q000139:chemically induced* / Q000517:prevention & control; D010053:Ovary / Q000187:drug effects*; D010062:Ovulation Induction / Q000009:adverse effects; D018873:Pregnancy Rate; D012307:Risk Factors; D020554:Sperm Injections, Intracytoplasmic
chemical_list: D006063:Chorionic Gonadotropin; D004958:Estradiol; D008596:Menotropins